BACKGROUND: Access to human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) is often poor in small urban and rural areas because of stigma and long distances to providers. The Iowa Department of Public Health and The University of Iowa created a regional telehealth program to address these barriers ("Iowa TelePrEP"). We describe initial TelePrEP results and share lessons learned. METHODS: Iowa Department of Public Health personnel in sexually transmitted infection (STI) clinics, disease intervention specialist and partner services, and HIV testing programs referred clients to pharmacists at University of Iowa. Clients could also self-refer via a website. Pharmacists completed video visits with clients in the community on smartphones and other devices, arranged local laboratory studies, and mailed medications. We performed a retrospective record review to quantify rates of PrEP referral, initiation, retention, guideline-concordant laboratory monitoring, and STI identification and treatment. RESULTS: Between February 2017 and October 2018, TelePrEP received 186 referrals (37% from public health) and completed 127 (68%) initial video visits with clients. Median client age was 32; 91% were men who have sex with men. Most clients with video visits (91%) started PrEP. Retention in TelePrEP at 6 months was 61%, and 96% of indicated laboratory monitoring tests were completed. Screening identified 37 STIs (8 syphilis, 10 gonorrhea, 19 chlamydia). Disease intervention specialist and partner services linked all clients with STIs to local treatment within 14 days (80% in 3 days). CONCLUSIONS: Using widely available technology and infrastructure, public health departments and health care systems can collaborate to develop regional telehealth programs to deliver PrEP in small urban and rural settings.
BACKGROUND: Access to human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) is often poor in small urban and rural areas because of stigma and long distances to providers. The Iowa Department of Public Health and The University of Iowa created a regional telehealth program to address these barriers ("Iowa TelePrEP"). We describe initial TelePrEP results and share lessons learned. METHODS: Iowa Department of Public Health personnel in sexually transmitted infection (STI) clinics, disease intervention specialist and partner services, and HIV testing programs referred clients to pharmacists at University of Iowa. Clients could also self-refer via a website. Pharmacists completed video visits with clients in the community on smartphones and other devices, arranged local laboratory studies, and mailed medications. We performed a retrospective record review to quantify rates of PrEP referral, initiation, retention, guideline-concordant laboratory monitoring, and STI identification and treatment. RESULTS: Between February 2017 and October 2018, TelePrEP received 186 referrals (37% from public health) and completed 127 (68%) initial video visits with clients. Median client age was 32; 91% were men who have sex with men. Most clients with video visits (91%) started PrEP. Retention in TelePrEP at 6 months was 61%, and 96% of indicated laboratory monitoring tests were completed. Screening identified 37 STIs (8 syphilis, 10 gonorrhea, 19 chlamydia). Disease intervention specialist and partner services linked all clients with STIs to local treatment within 14 days (80% in 3 days). CONCLUSIONS: Using widely available technology and infrastructure, public health departments and health care systems can collaborate to develop regional telehealth programs to deliver PrEP in small urban and rural settings.
Authors: Rebecca Bolinski; Kaitlin Ellis; Whitney E Zahnd; Suzan Walters; Colleen McLuckie; John Schneider; Christofer Rodriguez; Jerel Ezell; Samuel R Friedman; Mai Pho; Wiley D Jenkins Journal: Transl Behav Med Date: 2019-11-25 Impact factor: 3.046
Authors: Joseph G Rosen; Leanne Zhang; Danielle Pelaez; Jenell S Coleman; C To; Lyra Cooper; Praise F Olatunde; Teagan Toomre; Jennifer L Glick; Ju Nyeong Park Journal: AIDS Patient Care STDS Date: 2022-08 Impact factor: 5.944
Authors: Sheridan Miyamoto; Elizabeth Thiede; Elizabeth N Wright; Diane Berish; Daniel F Perkins; Cynthia Bittner; Lorah Dorn; Dennis Scanlon Journal: J Forensic Nurs Date: 2021 Jul-Sep 01 Impact factor: 1.175
Authors: Samuel D Powers; Elizabeth T Rogawski McQuade; Amy Killelea; Tim Horn; Kathleen A McManus Journal: Open Forum Infect Dis Date: 2021-06-04 Impact factor: 3.835
Authors: M Bryant Howren; Shelby L Francis; Linnea A Polgreen; Cody Shafer; Angela Hoth; Michael E Ohl Journal: Public Health Rep Date: 2020-10-27 Impact factor: 2.792